Switch theme
Sign up to access all valuation multiples
Emeis operates a comprehensive care offering of mental health clinics and medical and rehabilitation care, retirement homes, assisted living and home care.
1995
78.5K+
LTM Revenue $6.4B
LTM EBITDA $824M
$11.2B
Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.
Emeis has a last 12-month revenue (LTM) of $6.4B and a last 12-month EBITDA of $824M.
In the most recent fiscal year, Emeis achieved revenue of $5.8B and an EBITDA of $3.1B.
Emeis expects next 12-month revenue of XXX and NTM EBITDA of XXX
See Emeis valuation multiples based on analyst estimates| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Revenue | $6.4B | XXX | $5.8B | XXX | XXX | XXX |
| Gross Profit | $6.4B | XXX | $4.6B | XXX | XXX | XXX |
| Gross Margin | 100% | XXX | 79% | XXX | XXX | XXX |
| EBITDA | $824M | XXX | $3.1B | XXX | XXX | XXX |
| EBITDA Margin | 13% | XXX | 54% | XXX | XXX | XXX |
| EBIT | $39.7M | XXX | -$136M | XXX | XXX | XXX |
| EBIT Margin | 1% | XXX | -2% | XXX | XXX | XXX |
| Net Profit | -$387M | XXX | $1.5B | XXX | XXX | XXX |
| Net Margin | -6% | XXX | 26% | XXX | XXX | XXX |
| Net Debt | XXX | XXX | $4.5B | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
As of May 30, 2025, Emeis's stock price is EUR 10 (or $12).
Emeis has current market cap of EUR 1.7B (or $1.9B), and EV of EUR 10.0B (or $11.2B).
See Emeis trading valuation data| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $11.2B | $1.9B | XXX | XXX | XXX | XXX | $-2.16 |
Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more
Start Free TrialAs of May 30, 2025, Emeis has market cap of $1.9B and EV of $11.2B.
Emeis's trades at 1.9x EV/Revenue multiple, and 3.6x EV/EBITDA.
Equity research analysts estimate Emeis's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
Emeis has a P/E ratio of -4.8x.
See valuation multiples for Emeis and 12K+ public comps| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $1.9B | XXX | $1.9B | XXX | XXX | XXX |
| EV (current) | $11.2B | XXX | $11.2B | XXX | XXX | XXX |
| EV/Revenue | 1.7x | XXX | 1.9x | XXX | XXX | XXX |
| EV/EBITDA | 13.6x | XXX | 3.6x | XXX | XXX | XXX |
| EV/EBIT | 281.6x | XXX | -82.6x | XXX | XXX | XXX |
| EV/Gross Profit | 1.7x | XXX | n/a | XXX | XXX | XXX |
| P/E | -4.8x | XXX | 1.2x | XXX | XXX | XXX |
| EV/FCF | -817.9x | XXX | 44.3x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.
Start Free TrialEmeis's last 12 month revenue growth is 5%
Emeis's revenue per employee in the last FY averaged $0.1M, while opex per employee averaged $0.1M for the same period.
Emeis's rule of 40 is -69% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
Emeis's rule of X is 24% (created by Bessemer, rule of X is another metric relevant for SaaS companies only, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
See operational valuation multiples for Emeis and other 12K+ public comps| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Revenue Growth | 5% | XXX | 9% | XXX | XXX | XXX |
| EBITDA Margin | 13% | XXX | 54% | XXX | XXX | XXX |
| EBITDA Growth | 16% | XXX | n/a | XXX | XXX | XXX |
| Rule of 40 | -69% | XXX | 59% | XXX | XXX | XXX |
| Bessemer Rule of X | XXX | XXX | 24% | XXX | XXX | XXX |
| Revenue per Employee | XXX | XXX | $0.1M | XXX | XXX | XXX |
| Opex per Employee | XXX | XXX | $0.1M | XXX | XXX | XXX |
| S&M Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
| G&A Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
| R&D Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
| Opex to Revenue | XXX | XXX | 82% | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| 2025E | 2026E | 2027E | 2025E | 2026E | 2027E | |
| National Healthcare Corp | XXX | XXX | XXX | XXX | XXX | XXX |
| Regis Healthcare | XXX | XXX | XXX | XXX | XXX | XXX |
| Maternus-Kliniken | XXX | XXX | XXX | XXX | XXX | XXX |
| Addus HomeCare | XXX | XXX | XXX | XXX | XXX | XXX |
| Amedisys | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Emeis acquired XXX companies to date.
Last acquisition by Emeis was XXXXXXXX, XXXXX XXXXX XXXXXX . Emeis acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX ).
See M&A valuation multiples| Acquired Company | EV | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
Sign up to see revenue and EBITDA valuation multiples for 60K+ M&A deals.
Start Free Trial| When was Emeis founded? | Emeis was founded in 1995. |
| Where is Emeis headquartered? | Emeis is headquartered in France. |
| How many employees does Emeis have? | As of today, Emeis has 78.5K+ employees. |
| Who is the CEO of Emeis? | Emeis's CEO is Mr. Laurent Guillot. |
| Is Emeis publicy listed? | Yes, Emeis is a public company listed on PAR. |
| What is the stock symbol of Emeis? | Emeis trades under EMEIS ticker. |
| When did Emeis go public? | Emeis went public in 2002. |
| Who are competitors of Emeis? | Similar companies to Emeis include e.g. National Healthcare Corp, Regis Healthcare, Maternus-Kliniken, Addus HomeCare. |
| What is the current market cap of Emeis? | Emeis's current market cap is $1.9B |
| What is the current revenue of Emeis? | Emeis's last 12 months revenue is $6.4B. |
| What is the current revenue growth of Emeis? | Emeis revenue growth (NTM/LTM) is 5%. |
| What is the current EV/Revenue multiple of Emeis? | Current revenue multiple of Emeis is 1.7x. |
| Is Emeis profitable? | Yes, Emeis is EBITDA-positive (as of the last 12 months). |
| What is the current EBITDA of Emeis? | Emeis's last 12 months EBITDA is $824M. |
| What is Emeis's EBITDA margin? | Emeis's last 12 months EBITDA margin is 13%. |
| What is the current EV/EBITDA multiple of Emeis? | Current EBITDA multiple of Emeis is 13.6x. |
| What is the current FCF of Emeis? | Emeis's last 12 months FCF is -$13.7M. |
| What is Emeis's FCF margin? | Emeis's last 12 months FCF margin is 0%. |
| What is the current EV/FCF multiple of Emeis? | Current FCF multiple of Emeis is -817.9x. |
Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.
